From inflammation to fibrosis: Research explores cellular changes as COVID-19 lung damage worsens
Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind ...
The Brighterside of News on MSN6d
Popular health supplement shows promise in reversing lung damage
A recent study from the Women’s Guild Lung Institute at Cedars-Sinai suggests that zinc could help reverse lung damage in ...
AZoLifeSciences on MSN3d
Cellular changes as lung damage worsens in COVID-19 revealed
Changes in the cellular response during lung damage caused by SARS-CoV-2 – the virus behind COVID-19 – have been uncovered. Researchers reveal distinct phases where waves of immune responses give way ...
GEN - Genetic Engineering and Biotechnology News2d
Macrophages Fight COVID-19-Induced Lung Damage with Peroxisomes
Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.
Savara Announces U.S. Launch of the aPAP ClearPath™ Dried Blood Spot Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
mskcc.org17d
The Joo-Hyeon Lee Lab
England FE, Bordeu I, Ng ME, Bang J, Kim B, Choi J, Cardoso EC, Koo BK, Simons BD#, Lee JH#. Sustained NF-kB activation allows mutant alveolar stem cells to co-opt a regeneration program for tumor ...
Pharmabiz23d
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease
Unresectable alveolar soft part sarcoma has a poor prognosis, and no standard treatment has been established. Tecentriq is a cancer immune checkpoint inhibitor targeting PD-L1, which is a protein ...